Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Eggers, Maren ^a   Eickmann, Markus ^b   Kowalski, Katharina ^b   Zorn, Juergen ^c   Reimer, Karen ^c,d  

^a Labor Prof Gisela Enders MVZ GbR and the Institute of Virology Infectious Diseases and Epidemiology eV Stuttgart ^*  (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c MUNDIPHARMA GMBH   (Germany)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HAND SANITIZER; POVIDONE IODINE; TOPICAL ANTIINFECTIVE AGENT;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTACT TIME; CONTROLLED STUDY; CYTOTOXICITY; EBOLAVIRUS; HAND WASHING; IN VITRO STUDY; MODIFIED VACCINIA VIRUS ANKARA; NEWBORN; NONHUMAN; STANDARD; TIME; VACCINIA VIRUS; VIRAL PHENOMENA AND FUNCTIONS; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TITER; ANIMAL; CELL SURVIVAL; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; HEMORRHAGIC FEVER, EBOLA; HUMAN; VERO CELL LINE;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; EBOLAVIRUS; HAND HYGIENE; HEMORRHAGIC FEVER, EBOLA; HUMANS; POVIDONE-IODINE; VACCINIA VIRUS; VERO CELLS;

EID: 84941768707     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1111-9     Document Type: Article

References (37)

1. World Health Organization. Ebola virus disease. www.who.int/mediacentre/factsheets/fs103/en (2015). Accessed 30 July 2015.
2. World Health Organization. Frequently asked questions on Ebola virus disease. www.who.int/csr/disease/ebola/faq-ebola/en (2015). Accessed 30 July 2015.
3. World Health Organization. Ebola vaccines, therapies, and diagnostics. Questions and Answers. http://www.who.int/medicines/emp_ebola_q_as/en/ (2015). Accessed 30 Jul 2015.
4. Callaway E. Positive results spur race for Ebola vaccine. Nature. 2014;516:15-6.
5. Enserink M. The Ebola Epidemic. High hopes for Guinean vaccine trial. Science. 2015;347:219-20.
6. World Health Organization. Interim infection prevention and control guidance for care of patients with suspected or confirmed filovirus haemorrhagic fever in health-care settings, with focus on Ebola. http://www.who.int/csr/resources/who-ipc-guidance-ebolafinal-09082014.pdf (2014). Accessed 30 Jul 2015.
7. EN14476:2013/FprA1:2015. Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of virucidal activity in the medical area. Test method and requirements (Phase 2/Step 1). 2015.
8. Rabenau HF, Schwebke I, Blümel J, Eggers M, Glebe D, Rapp I, et al. Leitlinie der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten (DVV) e.V. und des Robert Koch-Instituts (RKI) zur Prüfung von chemischen Desinfektionsmitteln auf Wirksamkeit gegen Viren in der Humanmedizin [article in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015;58:493-504.
9. Rabenau HF, Rapp I, Steinmann J. Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants? BMC Infect Dis. 2010;185.
10. Stittelaar KJ, Kuiken T, de Swart RL, van Amerongen G, Vos HW, Niesters HG, et al. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine. 2001;19:3700-9.
11. Richmond JY, McKinney RW, editors. Biosafety in Microbiological and Biomedical Laboratories (4th ed). Washington: CDC-NIH; 1999.
12. Sparkes JD, Fenje P. The effect of residual moisture in lyophilized smallpox vaccine on its stability at different temperatures. Bull World Health Organ. 1972;46:729-34.
13. Hierholzer G, Reimer K, Weissenbacher ER, editors. Topische Infektionstherapie und Prophylaxe. Aktueller Stellenwert von PVP-Jod. Stuttgart: Thieme; 1996.
14. Fleischer W, Reimer K. Povidone Iodine in Antisepsis - State of the Art. Dermatology. 1997;195 Suppl 2:3-9.
15. Schreier H, Erdos G, Reimer K, Koenig B, Koenig W, Fleischer W. Molecular effects of povidone-iodine on relevant microorganisms: an electron microscopic and biochemical study. Dermatology. 1997;195 Suppl 2:111-6.
16. Wood A, Payne D. The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses. J Hosp Infect. 1998;38:283-95.
17. Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology. 1997;195 Suppl 2:29-35.
18. Wutzler P, Sauerbrei A, Klöcking R, Brögmann B, Reimer K. Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine. Antiviral Res. 2002;54:89-97.
19. Sauerbrei A, Sehr K, Eichhorn U, Reimer K, Wutzler P. Inactivation of human adenovirus genome by different groups of disinfectants. J Hosp Infect. 2004;57:67-72.
20. Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. Jpn J Vet Res. 2004;52:105-12.
21. Ito H, Ito T, Hikida M, Yashiro J, Otsuka A, Kida H, et al. Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products. Dermatology. 2006;212 Suppl 1:115-8.
22. Ito H, Hikida M, Yashiro J, Kida H, Ito T. Virucidal efficacy of povidone-iodine products against swine influenza viruses. Japanese Journal of Chemotherapy [article in Japanese]. 2009;57:508-10.
23. Sauerbrei A, Wutzler P. Virucidal efficacy of povidone-iodine-containing disinfectants. Lett Appl Microbiol. 2010;51:158-63.
24. Spearman C. The method of 'right and wrong cases' ('constant stimuli') without Gauss's formulae. Br J Psychol. 1908;2:227-42.
25. Kärber G. Beitrag zur Kollektiven Behandlung Pharmakologischer Reihenversuche [article in German]. Arch Exp Path Pharma. 1931;162:480-7.
26. ICH Q5A. Appendix 3: Statistical considerations for assessing virus assays. 1999.
27. Steinmann J, Paulmann D, Becker B, Bischoff B, Steinmann E, Steinmann J. Comparison of virucidal activity of alcohol-based hand sanitizers versus antimicrobial hand soaps in vitro and in vivo. J Hosp Infect. 2012;82:277-80.
28. Durani P, Leaper D. Povidone-iodine: use in hand disinfection, skin preparation and antiseptic irrigation. Int Wound J. 2008;5:376-87.
29. Jackson MM. Topical antiseptics in healthcare. Clin Lab Sci. 2005;18:160-9.
30. EN1500:2013 Chemical disinfectants and antiseptics. Hygienic handrub. Test method and requirements (Phase 2/Step 2). 2013.
31. Schurmann W, Eggers HJ. Antiviral activity of an alcoholic hand disinfectant: comparison of the in vitro suspension test with in vivo experiments on hands, and on individual fingertips. Antiviral Res. 1983;3:25-41.
32. Cambridge University Hospitals NHS Foundation Trust. Hand hygiene policy 1a. Version 13. http://www.cuh.org.uk/sites/default/files/publications/Hand%20hygiene%20policy%20%28IC1a%29%20version13%20January%202014.pdf . Accessed 30 Jul 2015.
33. Blackpool, Fylde and Wyre Hospitals NHS Foundation Trust. Hand Hygiene Procedure. Version 2. http://www.bfwh.nhs.uk/about/foi/part_two/cat8/documents/ic_docs/Corp_Proc_418.pdf (2008). Accessed 30 Jul 2015.
34. Sharma VS, Dutta S, Taneja N, Narang A. Comparing hand hygiene measures in a neonatal ICU: a randomized crossover trial. Indian Pediatr. 2013;50:917-21.
35. Australian Government Department of Health and Ageing. Laboratory procedures and precautions for samples collected from patients with suspected viral haemorrhagic fevers: guidelines for laboratories that are not associated with a designated isolation hospital. http://www.commcarelink.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-other-vhf.htm (2014). Accessed 30 Jul 2015.
36. Kramer A, Behrens-Baumann W. Prophylactic use of topical anti-infectives in ophthalmology. Ophthalmologica. 1997;211 Suppl 1:68-76.
37. Rudolph P, Fritze F, Reimer K, Klebingat KJ, Kramer A. Efficacy and local tolerability of povidone iodine (Betaisodona) and octenidine hydrochloride solution (Octenisept) for the antiseptic preparation of the orificium urethrae. Infection. 1999;27:108-13.